Literature DB >> 5370517

Adjustment of long-term survival rates for deaths due to intercurrent disease.

S J Cutler, L M Axtell, D Schottenfeld.   

Abstract

Mesh:

Year:  1969        PMID: 5370517     DOI: 10.1016/0021-9681(69)90010-1

Source DB:  PubMed          Journal:  J Chronic Dis        ISSN: 0021-9681


× No keyword cloud information.
  8 in total

1.  Baseline mortality-adjusted survival in colon cancer patients.

Authors:  Kristjan Ukegjini; Marcel Zadnikar; Rene Warschkow; Sascha Müller; Bruno M Schmied; Lukas Marti
Journal:  Langenbecks Arch Surg       Date:  2016-04-21       Impact factor: 3.445

2.  Choice of prosthetic heart valve in a developing country.

Authors:  Shiv Kumar Choudhary; Sachin Talwar; Balram Airan
Journal:  Heart Asia       Date:  2016-04-28

3.  Assessing methods--survival.

Authors:  S M Gore
Journal:  Br Med J (Clin Res Ed)       Date:  1981-09-26

4.  The biology of haematogenous metastasis in human uveal malignant melanoma.

Authors:  I W McLean
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993

5.  Adult soft tissue sarcomas. A pattern of care survey of the American College of Surgeons.

Authors:  W Lawrence; W L Donegan; N Natarajan; C Mettlin; R Beart; D Winchester
Journal:  Ann Surg       Date:  1987-04       Impact factor: 12.969

6.  Long-term survival of patients with breast cancer: a study of the curability of the disease.

Authors:  A O Langlands; S J Pocock; G R Kerr; S M Gore
Journal:  Br Med J       Date:  1979-11-17

7.  Minimum follow-up time required for the estimation of statistical cure of cancer patients: verification using data from 42 cancer sites in the SEER database.

Authors:  Patricia Tai; Edward Yu; Gábor Cserni; Georges Vlastos; Melanie Royce; Ian Kunkler; Vincent Vinh-Hung
Journal:  BMC Cancer       Date:  2005-05-17       Impact factor: 4.430

8.  Squamous carcinoma of the head and neck: cured fraction and median survival time as functions of age, sex, histologic type, and node status.

Authors:  J W Gamel; A S Jones
Journal:  Br J Cancer       Date:  1993-05       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.